Phase I Study of Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
Associated ConditionsLung Cancer
Moffitt Cancer Center
The main purpose of this study is to find out what effects (good and bad) ceritinib (Zykadia) used in combination with docetaxel (Taxotere) will have on you and your cancer.
This study is currently enrolling.